Lenalidomide Capsule
FDA Label NDC 70771-1679

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Lenalidomide (NDC 70771-1679). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1676-7

Lenalidomide Capsules, 2.5 mg

28 Capsules

Rx only

2.5 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 01)

2.5 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 01)

NDC 70771-1677-7

Lenalidomide Capsules, 5 mg

28 Capsules

Rx only

5 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 02)

5 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 02)

NDC 70771-1678-7

Lenalidomide Capsules, 10 mg

28 Capsules

Rx only

10 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 03)

10 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 03)

NDC 70771-1679-8

Lenalidomide Capsules, 15 mg

21 Capsules

Rx only

15 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 04)

15 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 04)

NDC 70771-1680-8

Lenalidomide Capsules, 20 mg

21 Capsules

Rx only

20 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 05)

20 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 05)

NDC 70771-1681-8

Lenalidomide Capsules, 25 mg

21 Capsules

Rx only

25 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 06)

25 mg Label (3a424203 8252 4be4 840f A574ef3afb1f 06)

* Please review the disclaimer below.